Is Ozempic a toy killer?

Is Ozempic a toy killer?

This morning Roche announced their way cool whiz bang CGM system the Accu-Chek SmartGuide secured a CE mark. This is good news for Roche as they are using the SmartGuide as bait to sell their entire diabetes franchise. Roche like other minor players has decided it’s time to exit the diabetes market. While it went largely unnoticed Ypsomed recently restructured, and they too are on their way out of diabetes.

Meanwhile Lilly and Novo Nordisk continue to power ahead as sales of Ozempic, Wegovy, Mounjaro and Zepbound show no signs of letting up anytime soon. Talk about living . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.